Ethinylestradiol/gestodene

(Redirected from Mirelle)

Ethinylestradiol/gestodene (EE/GSD), sold under the brand names Femodene and Minulet among others, is a combination of ethinylestradiol (EE), an estrogen, and gestodene (GSD), a progestin, which is used as a birth control pill to prevent pregnancy in women.[1][2] It is taken by mouth and contains 20 or 30 μg EE and 0.075 mg GSD per tablet.[1][2] EE/GSD is marketed widely throughout the world.[3]

Ethinylestradiol/gestodene
Ethinylestradiol
Gestodene
Combination of
EthinylestradiolEstrogen
GestodeneProgestogen; Progestin
Clinical data
Trade namesFemodene, Gynera, Harmonet, Lindynette, Logest, Meliane, Minesse, Minulet, Mirelle, others
Other namesEE/GSD
Routes of
administration
By mouth
Drug classEstrogen; Progestin; Progestogen
Legal status
Legal status
Identifiers
CAS Number

See also

edit

References

edit
  1. ^ a b IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 440–. ISBN 978-92-832-1291-1.
  2. ^ a b Bartke A, Constanti A (9 July 2003). Basic Endocrinology. Taylor & Francis. pp. 128–. ISBN 978-1-135-29850-0.
  3. ^ "Gestodene". drugs.com.